Literature DB >> 22813998

Motor resonance mechanisms are preserved in Alzheimer's disease patients.

A Bisio1, M Casteran, Y Ballay, P Manckoundia, F Mourey, T Pozzo.   

Abstract

This study aimed to better characterize the sensorimotor mechanisms underlying motor resonance, namely the relationship between motion perception and movement production in patients suffering from Alzheimer's disease (AD). This work first gives a kinematic description of AD patients' upper limb movements, then it presents a simple paradigm in which a dot with different velocities is moved in front of the participant who is instructed to point to its final position when it stopped. AD patients' actions, as well as healthy elderly participants, were similarly influenced by the dot velocity, suggesting that motor resonance mechanisms are not prevented by pathology. In contrast, only patients had anticipatory motor response: i.e. they started moving before the end of the stimulus motion, unlike what was requested by the experimenter. While the automatic imitation of the stimulus suggests an intact ability to match the internal motor representations with that of the visual model, the uncontrolled motion initiation would indicate AD patients' deficiency to voluntarily inhibit response production. These findings might open new clinical perspectives suggesting innovative techniques in training programs for people with dementia. In particular, the preservation of the motor resonance mechanisms, not dependent on conscious awareness, constitutes an intact basis upon which clinicians could model both physical and cognitive interventions for healthy elderly and AD patients. Furthermore, the evaluation of the inhibitory functions, less sensitive to the level of education than other methods, might be useful for screening test combined with the traditional AD techniques. However, further investigations to understand if this feature is specific to AD or is present also in other neurodegenerative diseases are needed.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22813998     DOI: 10.1016/j.neuroscience.2012.07.017

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Motor contagion during human-human and human-robot interaction.

Authors:  Ambra Bisio; Alessandra Sciutti; Francesco Nori; Giorgio Metta; Luciano Fadiga; Giulio Sandini; Thierry Pozzo
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

2.  Voluntary Imitation in Alzheimer's Disease Patients.

Authors:  Ambra Bisio; Matthieu Casteran; Yves Ballay; Patrick Manckoundia; France Mourey; Thierry Pozzo
Journal:  Front Aging Neurosci       Date:  2016-03-07       Impact factor: 5.750

3.  The kinematics of handwriting movements as expression of cognitive and sensorimotor impairments in people with multiple sclerosis.

Authors:  Ambra Bisio; Ludovico Pedullà; Laura Bonzano; Andrea Tacchino; Giampaolo Brichetto; Marco Bove
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

4.  Effect of Group-Based Rehabilitation Combining Action Observation with Physiotherapy on Freezing of Gait in Parkinson's Disease.

Authors:  Elisa Pelosin; Roberta Barella; Cristina Bet; Elisabetta Magioncalda; Martina Putzolu; Francesca Di Biasio; Cecilia Cerulli; Mauro Casaleggio; Giovanni Abbruzzese; Laura Avanzino
Journal:  Neural Plast       Date:  2018-05-27       Impact factor: 3.599

5.  Mental Rotation as an Indicator of Motor Representation in Patients with Mild Cognitive Impairment.

Authors:  Julien Bourrelier; Alexandre Kubicki; Olivier Rouaud; Lionel Crognier; France Mourey
Journal:  Front Aging Neurosci       Date:  2015-12-23       Impact factor: 5.750

6.  Postural Stabilization Strategies to Motor Contagion Induced by Action Observation Are Impaired in Parkinson's Disease.

Authors:  Elisa Pelosin; Ambra Bisio; Thierry Pozzo; Giovanna Lagravinese; Oscar Crisafulli; Roberta Marchese; Giovanni Abbruzzese; Laura Avanzino
Journal:  Front Neurol       Date:  2018-03-01       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.